SEC-sourced researchBeta
RGNX
REGENXBIO Inc.
Company comparison ↗
Data passport
- CIK
- 0001590877
- Exchange
- Nasdaq
- Business activity
- — · SIC 2836
- Financial inputs
- 6/6
- Filing date
- Sep 23, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 83,328,000.0000 | Mar 5, 2026 |
| December 2025 | 170,441,000.0000 | Mar 5, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 170,441,000.0000 | -193,878,000.0000 | -123,963,000.0000 | 453,032,000.0000 | 350,299,000.0000 | Mar 5, 2026 |
| December 2024 | 83,328,000.0000 | -227,102,000.0000 | -173,125,000.0000 | 465,989,000.0000 | 206,338,000.0000 | Mar 5, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $170.44M | December 2025 | Mar 5, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $83.33M | December 2024 | Mar 5, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$193.88M | December 2025 | Mar 5, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$123.96M | December 2025 | Mar 5, 2026 | 10-K |
| Total assetsAssets | $453.03M | December 2025 | Mar 5, 2026 | 10-K |
| Total liabilitiesLiabilities | $350.3M | December 2025 | Mar 5, 2026 | 10-K |